<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Br J Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Br. J. Pharmacol</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1476-5381</journal-id>
<journal-id journal-id-type="publisher-id">BPH</journal-id>
<journal-title-group>
<journal-title>British Journal of Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0007-1188</issn>
<issn pub-type="epub">1476-5381</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28707298</article-id>
<article-id pub-id-type="pmc">6057902</article-id>
<article-id pub-id-type="doi">10.1111/bph.13950</article-id>
<article-id pub-id-type="publisher-id">BPH13950</article-id>
<article-id pub-id-type="other">2017-BJP-0527-RCT-G.R2</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Themed Section: Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Melatonin receptors: molecular pharmacology and signalling in the context of system bias</article-title>
<alt-title alt-title-type="right-running-head">Melatonin receptor system bias</alt-title>
<alt-title alt-title-type="left-running-head">E Cecon et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="bph13950-cr-0001">
<name>
<surname>Cecon</surname>
<given-names>Erika</given-names>
</name>
<xref ref-type="aff" rid="bph13950-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="bph13950-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="bph13950-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13950-cr-0002">
<name>
<surname>Oishi</surname>
<given-names>Atsuro</given-names>
</name>
<xref ref-type="aff" rid="bph13950-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="bph13950-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="bph13950-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="bph13950-cr-0003">
<name>
<surname>Jockers</surname>
<given-names>Ralf</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4354-1750</contrib-id>
<address>
<email>ralf.jockers@inserm.fr</email>
</address>
<xref ref-type="aff" rid="bph13950-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="bph13950-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="bph13950-aff-0003">
<sup>3</sup>
</xref>
</contrib>
</contrib-group>
<aff id="bph13950-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Institut Cochin</named-content>
<institution>Inserm, U1016</institution>
<named-content content-type="city">Paris</named-content>
<country country="FR">France</country>
</aff>
<aff content-type="private-address" id="bph13950-aff-0002">
<label><sup>2</sup></label>
<institution>CNRS UMR 8104</institution>
<named-content content-type="city">Paris</named-content>
<country country="FR">France</country>
</aff>
<aff content-type="private-address" id="bph13950-aff-0003">
<label><sup>3</sup></label>
<institution>Univ. Paris Descartes, Sorbonne Paris Cité</institution>
<named-content content-type="city">Paris</named-content>
<country country="FR">France</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>
Correspondence<break></break>
Ralf Jockers, Institut Cochin, Inserm, U1016, 22 rue Méchain, 75014 Paris, France.<break></break>
E‐mail: <email>ralf.jockers@inserm.fr</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2018</year>
</pub-date>
<volume>175</volume>
<issue>16</issue>
<issue-id pub-id-type="doi">10.1111/bph.v175.16</issue-id>
<issue-title content-type="special-issue-title">Themed Section: Recent Developments in Research of Melatonin and its Potential Therapeutic Applications. Guest Editor: S C Stanford</issue-title>
<fpage>3263</fpage>
<lpage>3280</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>05</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 The British Pharmacological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 The British Pharmacological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:BPH-175-3263.pdf" xlink:type="simple"></self-uri>
<abstract>
<sec id="bph13950-sec-0050">
<p>Melatonin, <styled-content style="italic-in-any-context">N</styled-content>‐acetyl‐5‐methoxytryptamine, an evolutionally old molecule, is produced by the pineal gland in vertebrates, and it binds with high affinity to melatonin receptors, which are members of the GPCR family. Among the multiple effects attributed to melatonin, we will focus here on those that are dependent on the activation of the two mammalian MT<sub>1</sub> and MT<sub>2</sub> melatonin receptors. We briefly summarize the latest developments on synthetic melatonin receptor ligands, including multi‐target‐directed ligands, and the characterization of signalling‐biased ligands. We discuss signalling pathways activated by melatonin receptors that appear to be highly cell‐ and tissue‐dependent, emphasizing the impact of system bias on the functional outcome. Different proteins have been demonstrated to interact with melatonin receptors, and thus, we postulate that part of this system bias has its molecular basis in differences of the expression of receptor‐associated proteins including heterodimerization partners. Finally, bias at the level of the receptor, by the expression of genetic receptor variants, will be discussed to show how a modified receptor function can have an effect on the risk for common diseases like type 2 diabetes in humans.</p>
</sec>
<sec id="bph13950-sec-0051">
<title>Linked Articles</title>
<p>This article is part of a themed section on Recent Developments in Research of Melatonin and its Potential Therapeutic Applications. To view the other articles in this section visit <ext-link ext-link-type="uri" xlink:href="http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.16/issuetoc">http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.16/issuetoc</ext-link>
</p>
</sec>
</abstract>
<funding-group>
<award-group>
<funding-source>Centre National de la Recherche Scientifique (CNRS)</funding-source>
</award-group>
<award-group>
<funding-source>Institut National de la Santé et de la Recherche Médicale (INSERM)</funding-source>
</award-group>
<award-group>
<funding-source>Agence Nationale de la Recherche</funding-source>
<award-id>ANR‐11‐IDEX‐0005‐01</award-id>
<award-id>ANR‐12‐RPIB‐0016 ‘MED‐HET‐REC‐2’</award-id>
<award-id>ANR‐2011‐META ‘MELA‐BETES’</award-id>
<award-id>ANR 2011‐BSV1‐012‐01 ‘MLT2D’</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="1"></table-count>
<page-count count="18"></page-count>
<word-count count="7750"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>bph13950</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>August 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.4 mode:remove_FC converted:24.07.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="bph13950-cit-0000" publication-type="journal">
<string-name>
<surname>Cecon</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Oishi</surname>, <given-names>A.</given-names>
</string-name>, and <string-name>
<surname>Jockers</surname>, <given-names>R.</given-names>
</string-name> (<year>2018</year>) <article-title>Melatonin receptors: molecular pharmacology and signalling in the context of system bias</article-title>. <source xml:lang="en"/>British Journal of Pharmacology, <volume>175</volume>: <fpage>3263</fpage>–<lpage>3280</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13950</pub-id>.</mixed-citation>
</p>
</notes>
</front>
</article>
</pmc-articleset>